Related Experiment Videos
Pharmacogenomics and genetics of primary hypertension
1University Vita Salute San Raffaele, Division of Nephrology, Dialysis and Hypertension, San Raffaele Hospital, Via Olgettina, 60, 20132 Milan, Italy. bianchi.giuseppe@hsr.it
Current Hypertension Reports
|December 6, 2001
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension.
Lancet (London, England)·1997
Isozyme-dependent sensitivity of adenylyl cyclases to P-site-mediated inhibition by adenine nucleosides and nucleoside 3'-polyphosphates.
The Journal of biological chemistry·1997
Nonacidotic proximal tubulopathy transmitted as autosomal dominant trait.
American journal of kidney diseases : the official journal of the National Kidney Foundation·1997
IL-2-regulated expression of the monocyte chemotactic protein-1 receptor (CCR2) in human NK cells: characterization of a predominant 3.4-kilobase transcript containing CCR2B and CCR2A sequences.
Journal of immunology (Baltimore, Md. : 1950)·1997
Glutathione kinetics in normal man and in patients with liver cirrhosis.
Journal of hepatology·1997
Occupational Physical Activity and Hypertension: A Narrative Review.
Current hypertension reports·2026
Parental Obesity and Offspring Risk for Cardiorenal Diseases.
Current hypertension reports·2026
MASLD and Cardiovascular Risk: Mechanisms and Implications for Clinical Practice.
Current hypertension reports·2026
Toward Precision Aspirin Prophylaxis: Optimal Aspirin Dosing For Prevention of Preeclampsia.
Current hypertension reports·2026
Neural Control of Tissue Perfusion: Emerging Evidence and Beyond.
Current hypertension reports·2026
Intersection of Pediatric Hypertension and Cardiovascular-Kidney-Metabolic Disease.
Current hypertension reports·2026
Evaluating seltorexant as a treatment option for major depressive disorder.
Expert review of neurotherapeutics·2026
Effects of subcutaneous semaglutide on weight loss and inflammatory markers in adults with overweight or obesity without diabetes: a systematic review and meta-analysis.
International journal of obesity (2005)·2026